Phase 1 Study of OLX-07010 in Healthy Adult and Elderly Participants

Inclusion Criteria: * Participant voluntarily agrees to participate and signs an approved informed consent prior to performing any of the Screening Visit procedures. * Participant must be a healthy male or female of non-childbearing potential 18 to 50 years old inclusive, in Part 1, 2, and 4 of the study. Participant must be a healthy elderly male or female of non-childbearing potential 51-75 years old inclusive in Part 3 of the study. * Male participants with body weight ≥ 55 kg; and females with body weight ≥ 50 kg and body mass index (BMI) between 18 and 30 kg/m2 (inclusive) for Part 1, 2, and 4 of the study; and BMI between 18 and 32 kg/m2 (inclusive) for Part 3 of the study. * Female participants must be of non-childbearing potential (surgically sterile \[hysterectomy or bilateral tubal ligation\] or postmenopausal ≥ 1 year with follicle -stimulating hormone \[FSH\] \> 40 IU/L at screening). Exclusion Criteria: * Participant has clinically significant history or evidence of cardiovascular (CV), respiratory, hepatic, renal, gastrointestinal, endocrine, neurological, immunological, or psychiatric disorder(s). * Participant has any disorder that would interfere with the absorption, distribution, metabolism or excretion of drugs. * Participant has a history of hypersensitivity to the study drug or any of the excipients or to medicinal products with similar chemical structures. * Treatment with any investigational drug within the past 30 days prior to dosing. * Use of any …